Филиал ООО «Джонсон & Джонсон» в РК

Филиал ООО «Джонсон & Джонсон» в РК выражает Вам свое почтение и настоящим информирует о решении прекращения ввоза на территорию РК препарата Олисио®, капсулы 150 мг №7 и №28, и соответственно внесения каких-либо изменений в регистрационное досье препарата в будущем в связи с решением бизнеса.
Данное решение не связано с качеством, эффективностью и безопасностью применения препарата. Компания гарантирует проведение мониторинга всех нежелательных явлений и жалоб на качество продукции до истечения срока годности препарата Олисио®, находящегося на фармацевтическом рынке Республики Казахстан.

Результаты (английский) 1:

Branch of LLC "Johnson & Johnson" in the ROK expressed its respect to you and hereby informs the decision terminating the importation into the territory of the Republic of Kazakhstan of the drug Olisio ® 150 mg capsules No. 7 and no. 28 and, consequently, any changes in the registration dossier preparation in the future in connection with the decision of the business. This decision is not related to the quality, effectiveness and safety of drugs. The company guarantees all adverse events monitoring and complaints about the quality of the product before the expiration date of the drug Olisio ®, located in the pharmaceutical market of the Republic of Kazakhstan.

Результаты (английский) 2:

Filial "Johnson & Johnson" in the Republic of Kazakhstan expresses its respect and hereby informs the decision to cease the importation into the territory of the Republic of Kazakhstan Olisio® drug capsules 150 mg №7 and №28, and therefore making any changes in the registration dossier of the drug in the future due to business decision.
This decision is not related to quality, safety and efficacy of the drug. The company guarantees the monitoring of adverse events and complaints about the quality of the product until the expiration date of the drug Olisio® located on the pharmaceutical market of the Republic of Kazakhstan.

Результаты (английский) 3:

branch company "johnson & johnson rk expresses its respect and hereby informs about the decision of the smuggling of drugs into олисио®, 150 mg capsules no.7 and no. 28, and accordingly, any changes in the registration dossier preparation in the future for the business.
this decision has nothing to do with the quality, efficiency and safety of the drug. the company ensures the monitoring of all undesirable phenomena and complaints on the quality of products by the expiration date of the drug олисио®, in the pharmaceutical market of the republic of kazakhstan.